FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204131807> ?p ?o ?g. }

• W3204131807 endingPage "3371" @default.
• W3204131807 startingPage "3366" @default.
• W3204131807 abstract "BACKGROUND Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterised by progressive dyspnoea on exertion and cough. COPD is associated with comorbidities that influence mortality and hospitalizations independently. Metabolic syndrome (MS) consists of central obesity, hypertriglyceridemia, low levels of high-density lipoprotein (HDL), hyperglycaemia and hypertension. Presence of metabolic syndrome in patients with COPD increases the frequency of exacerbations and their duration. This study was done to find out prevalence of metabolic syndrome in COPD patients and its influence on exacerbations. METHODS This prospective observational study was conducted in a tertiary care teaching hospital in South India. 174 patients meeting the inclusion criteria were recruited for this prospective observational study, out of which 13 were excluded due to various reasons. Selected patients underwent detailed clinical examination and investigations including chest X-ray, spirometry, fasting blood sugar, fasting lipid profile, electrocardiogram (ECG) etc. Patients were further grouped in to those with metabolic syndrome and those without. They were followed up for one year with review on every two months for assessing exacerbation of COPD. Data was evaluated at the end of the study, statistical evaluation was done using Statistical Package for Social Sciences (SPSS software version18). RESULTS A total of 174 patients were recruited for the study, among which 13 were excluded. 161 patients were included in the final evaluation, out of which 157 patients were male (97.5 %). 44.7 % were belonging to global initiative for obstructive lung disease (GOLD stage III), 37.3 % stage IV and 18 % stage II. 70 (43.5 %) had metabolic syndrome. 51.6 % had normal body mass index (BMI), 23.6 % over weight and 3.7 % were obese. Mean number of exacerbations were 3.20 in those with metabolic syndrome, whereas 1.52 in those without, during the follow up period. CONCLUSIONS Prevalence of metabolic syndrome among COPD patients was 43.5 % in this study. COPD patients with metabolic syndrome had more mean number of exacerbations than those without metabolic syndrome. KEYWORDS COPD, Exacerbations, Metabolic Syndrome, Co-morbidities" @default.
• W3204131807 created "2021-10-11" @default.
• W3204131807 creator A5059736449 @default.
• W3204131807 creator A5063670484 @default.
• W3204131807 creator A5085226146 @default.
• W3204131807 date "2021-09-20" @default.
• W3204131807 modified "2023-09-24" @default.
• W3204131807 title "Prevalence of Metabolic Syndrome in COPD Patients Attending a Tertiary Care Setting, at Kozhikode District in Kerala" @default.
• W3204131807 doi "https://doi.org/10.18410/jebmh/2021/611" @default.
• W3204131807 hasPublicationYear "2021" @default.
• W3204131807 type Work @default.
• W3204131807 sameAs 3204131807 @default.
• W3204131807 citedByCount "0" @default.
• W3204131807 crossrefType "journal-article" @default.
• W3204131807 hasAuthorship W3204131807A5059736449 @default.
• W3204131807 hasAuthorship W3204131807A5063670484 @default.
• W3204131807 hasAuthorship W3204131807A5085226146 @default.
• W3204131807 hasConcept C126322002 @default.
• W3204131807 hasConcept C1862650 @default.
• W3204131807 hasConcept C188816634 @default.
• W3204131807 hasConcept C23131810 @default.
• W3204131807 hasConcept C2776042228 @default.
• W3204131807 hasConcept C2776780178 @default.
• W3204131807 hasConcept C2776919658 @default.
• W3204131807 hasConcept C2777014857 @default.
• W3204131807 hasConcept C2778163477 @default.
• W3204131807 hasConcept C2778913445 @default.
• W3204131807 hasConcept C2780333948 @default.
• W3204131807 hasConcept C2780578515 @default.
• W3204131807 hasConcept C511355011 @default.
• W3204131807 hasConcept C71924100 @default.
• W3204131807 hasConceptScore W3204131807C126322002 @default.
• W3204131807 hasConceptScore W3204131807C1862650 @default.
• W3204131807 hasConceptScore W3204131807C188816634 @default.
• W3204131807 hasConceptScore W3204131807C23131810 @default.
• W3204131807 hasConceptScore W3204131807C2776042228 @default.
• W3204131807 hasConceptScore W3204131807C2776780178 @default.
• W3204131807 hasConceptScore W3204131807C2776919658 @default.
• W3204131807 hasConceptScore W3204131807C2777014857 @default.
• W3204131807 hasConceptScore W3204131807C2778163477 @default.
• W3204131807 hasConceptScore W3204131807C2778913445 @default.
• W3204131807 hasConceptScore W3204131807C2780333948 @default.
• W3204131807 hasConceptScore W3204131807C2780578515 @default.
• W3204131807 hasConceptScore W3204131807C511355011 @default.
• W3204131807 hasConceptScore W3204131807C71924100 @default.
• W3204131807 hasIssue "38" @default.
• W3204131807 hasLocation W32041318071 @default.
• W3204131807 hasOpenAccess W3204131807 @default.
• W3204131807 hasPrimaryLocation W32041318071 @default.
• W3204131807 hasRelatedWork W2042136708 @default.
• W3204131807 hasRelatedWork W2509081055 @default.
• W3204131807 hasRelatedWork W2777951837 @default.
• W3204131807 hasRelatedWork W2791454230 @default.
• W3204131807 hasRelatedWork W2884066209 @default.
• W3204131807 hasRelatedWork W3110942203 @default.
• W3204131807 hasRelatedWork W3215551124 @default.
• W3204131807 hasRelatedWork W4214950067 @default.
• W3204131807 hasRelatedWork W4353092075 @default.
• W3204131807 hasRelatedWork W2406682690 @default.
• W3204131807 hasVolume "8" @default.
• W3204131807 isParatext "false" @default.
• W3204131807 isRetracted "false" @default.
• W3204131807 magId "3204131807" @default.
• W3204131807 workType "article" @default.